Search research articles
Contact Us
Filters
Showing results (11-20 of 142) with videos related to
Page
of 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 5, 2004
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
Bernard Le Foll, Steven R Goldberg
Addiction (Abingdon, England)
|
November 23, 2007
Self-administration of drugs in animals and humans as a model and an investigative tool
Leigh V Panlilio, Steven R Goldberg
Pharmacological Research
|
October 16, 2007
Endocannabinoid system involvement in brain reward processes related to drug abuse
Marcello Solinas, Sevil Yasar, Steven R Goldberg
Plos One
|
February 22, 2007
High reinforcing efficacy of nicotine in non-human primates
Bernard Le Foll, Carrie Wertheim, Steven R Goldberg
Pharmacology & Therapeutics
|
January 22, 2013
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction
Leigh V Panlilio, Zuzana Justinova, Steven R Goldberg
British Journal of Pharmacology
|
July 2, 2010
Animal models of cannabinoid reward
Leigh V Panlilio, Zuzana Justinova, Steven R Goldberg
Behavioural Pharmacology
|
February 24, 2006
Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats
Bernard Le Foll, Marcus Wiggins, Steven R Goldberg
Neuropharmacology
|
June 21, 2005
The dopamine D3 receptor and drug dependence: effects on reward or beyond?
Bernard Le Foll, Steven R Goldberg, Pierre Sokoloff
Current Topics in Behavioral Neurosciences
|
November 25, 2010
Drug addiction
Zuzana Justinova, Leigh V Panlilio, Steven R Goldberg
Expert Opinion on Investigational Drugs
|
December 13, 2006
Dopamine D3 receptor ligands for the treatment of tobacco dependence
Bernard Le Foll, Steven R Goldberg, Pierre Sokoloff
Page
of 15
Search research articles
Search
Showing results (11-20 of 142) with videos related to
Sort By:
Page
of 15
The Journal of Pharmacology and Experimental Therapeutics
|
November 5, 2004
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
Bernard Le Foll, Steven R Goldberg
Addiction (Abingdon, England)
|
November 23, 2007
Self-administration of drugs in animals and humans as a model and an investigative tool
Leigh V Panlilio, Steven R Goldberg
Pharmacological Research
|
October 16, 2007
Endocannabinoid system involvement in brain reward processes related to drug abuse
Marcello Solinas, Sevil Yasar, Steven R Goldberg
Plos One
|
February 22, 2007
High reinforcing efficacy of nicotine in non-human primates
Bernard Le Foll, Carrie Wertheim, Steven R Goldberg
Pharmacology & Therapeutics
|
January 22, 2013
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction
Leigh V Panlilio, Zuzana Justinova, Steven R Goldberg
British Journal of Pharmacology
|
July 2, 2010
Animal models of cannabinoid reward
Leigh V Panlilio, Zuzana Justinova, Steven R Goldberg
Behavioural Pharmacology
|
February 24, 2006
Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats
Bernard Le Foll, Marcus Wiggins, Steven R Goldberg
Neuropharmacology
|
June 21, 2005
The dopamine D3 receptor and drug dependence: effects on reward or beyond?
Bernard Le Foll, Steven R Goldberg, Pierre Sokoloff
Current Topics in Behavioral Neurosciences
|
November 25, 2010
Drug addiction
Zuzana Justinova, Leigh V Panlilio, Steven R Goldberg
Expert Opinion on Investigational Drugs
|
December 13, 2006
Dopamine D3 receptor ligands for the treatment of tobacco dependence
Bernard Le Foll, Steven R Goldberg, Pierre Sokoloff
Page
of 15